Outpatiented · Case Knowledge
His blood sugar was 50. He was told to drink something sugary immediately. He interrupted to say he had a peanut butter and jelly sandwich two hours ago. His sugar was still 50. He drank a Coke while on the phone. It came right up. That one moment contains everything wrong with how diabetes education actually works.
The Moment
Blood sugar at 50. Actively symptomatic. The call went the way these calls go: drink fast sugar right now. He interrupted. He had eaten a peanut butter and jelly sandwich two hours ago. He said it like that settled something.
He was still at 50.
This is not a stupidity problem. It is an information problem. He had a theory: eating raises blood sugar. The theory is correct. The application was wrong. Peanut butter is fat and protein. Jelly is sugar, but paired with fat and protein, absorption slows significantly. A peanut butter and jelly sandwich is not fast sugar. At an active blood sugar of 50, you need glucose in the bloodstream within minutes, not a slow-release mixed meal that will peak ninety minutes later.
He drank a Coke while still on the phone. His sugar came up. He said he felt better.
The fix took three minutes. The information that would have prevented the whole situation should have been provided the day Mounjaro was prescribed.
He had a theory and he was defending it against a live glucometer reading.
The reading was right.
Fast Carb vs Slow Carb
When blood sugar drops into dangerous range, the goal is to get glucose into the bloodstream fast. Not food into the stomach. Into the bloodstream. Those are not the same thing.
Fat and protein slow gastric emptying and slow glucose absorption. A peanut butter sandwich will eventually raise blood sugar. At an active 50 it is the wrong tool because eventually is too slow.
The Mounjaro Mechanism
This patient was on metformin 1000mg twice daily and Jardiance (empagliflozin). He had no hypoglycemic events. That is expected: metformin does not cause hypoglycemia. Jardiance does not cause hypoglycemia. Both are essentially zero intrinsic hypo risk. His regimen was stable and he was doing fine.
Mounjaro (tirzepatide) was added. He started dropping to blood sugars in the 50s.
Tirzepatide is a GIP and GLP-1 receptor agonist. It does not directly cause hypoglycemia in the way insulin or sulfonylureas do. Its intrinsic hypo risk as monotherapy is low. So why is he dropping?
Mounjaro is highly effective at suppressing appetite. That is a core mechanism. Patients eat less. Often significantly less. In a person whose diabetes regimen was calibrated to a certain intake pattern, eating substantially less while the medication load stays the same creates a mismatch. The drugs are still doing their job. The fuel going in has dropped. The result is lower blood sugar, and in the afternoon window when the last meal is several hours back, it can drop into hypoglycemic range.
GLP-1 agonists including tirzepatide slow gastric emptying. This is part of how they reduce post-meal glucose spikes. But it also means that when the patient does eat, glucose absorption is more delayed than before. A meal that would have raised blood sugar within an hour now raises it later. The combination of eating less and absorbing more slowly, against an unchanged regimen, creates the 3 to 4 PM drop pattern.
When Mounjaro is added to an existing regimen, guidelines recommend reassessing the doses of other glucose-lowering agents, particularly insulin and sulfonylureas, to account for the additional effect and reduced intake. In this case there was no insulin or sulfonylurea in the mix. The lows are being driven by intake reduction against a stable background regimen. The solution is tracking intake, tracking glucose readings, and bringing that data to the prescriber. The prescriber may adjust timing, suggest a different snack pattern, or modify the regimen. That conversation needs data.
He was never told that Mounjaro would suppress his appetite significantly. He was never told that eating less while his regimen stayed the same could cause blood sugar to drop. He was never told what afternoon hypoglycemia looks like before it becomes a 50 on a glucometer. He was never told what fast carbs versus slow carbs means in the context of an active low.
He had no model for what was happening to him. When you have no model, a blood sugar of 50 two hours after eating a sandwich is confusing and frightening rather than mechanistically obvious. He defended the sandwich because the sandwich made sense in the model he had.
This is not a failure of intelligence. It is a failure of front-loading. The information that would have prevented this moment existed before the prescription was written. It was not delivered.
The Part Under the Information Gap
He was told to track his glucose readings. Track his food intake. Bring that to his prescriber. He pushed back.
This is not unusual. The information problem is real but it is not the whole story. When the answer is 'this is yours to track, yours to log, yours to bring to your doctor,' that assigns work to the person who called in hoping someone else would solve it. The ego layer is not about being wrong. It is about not wanting to be the one who has to change.
The peanut butter sandwich defense was the same thing. He had done something. He had eaten. In his model, doing something meant the problem was handled. Being told the thing he did was the wrong thing for this situation meant the problem was still his, and now he was also wrong.
You cannot hand someone ownership of their health in a phone call. What you can do is structure the lift so it is small enough they will actually do it. A tracking template. A conversation with the prescriber framed for them so they are not walking in empty-handed. A clear explanation of what to watch for next time so the 50 does not become a 40 before they act.
The Coke worked in real time. That is the only moment when the mechanism became undeniable because it became a sensation. That thirty-second window when abstraction turns physical is the only real teaching window you get. The rest has to be built before the crisis.
The information you can hand them.
The ownership you can only make small enough to take.
Questions People Actually Ask
Can Mounjaro cause hypoglycemia?
Mounjaro (tirzepatide) has low intrinsic risk of causing hypoglycemia as monotherapy. It does not work the way insulin or sulfonylureas work. On its own, it is unlikely to drop your blood sugar to dangerous levels.
The risk comes indirectly. Tirzepatide significantly suppresses appetite, so people eat less. It also slows gastric emptying, so what they do eat absorbs more slowly. If the rest of the diabetes regimen stays unchanged while intake drops, the glucose-lowering load stays the same but the glucose going in does not. That mismatch is what causes the lows, particularly in the afternoon hours when the last meal is several hours back.
If hypoglycemic events start after adding Mounjaro to an existing regimen, that is a conversation for the prescribing physician. The regimen may need to be adjusted to account for reduced intake.
What should I eat or drink when my blood sugar is low?
For an active low, you need fast-absorbing carbohydrates. The goal is glucose in the bloodstream within 15 minutes, not food in the stomach.
Fast options: regular soda (4 to 8 ounces, not diet), glucose tablets (15 to 20 grams), fruit juice (4 ounces), hard candy (check the label for carb count), or plain sugar dissolved in water.
What to avoid in the moment: peanut butter, cheese, chocolate bars, milk, or any food with significant fat or protein. Fat and protein slow gastric emptying and slow glucose absorption. They will eventually raise blood sugar, but at an active 50 they are too slow. Treat the low first with fast carbs. Eat a mixed snack afterward to prevent another drop.
Why does my blood sugar drop in the afternoon on Mounjaro?
The 3 to 4 PM window is a common time for this because it is typically 3 to 5 hours after lunch, and on Mounjaro many people are eating less at lunch than before. If the glucose-lowering effect of your other medications is calibrated to a previous intake pattern, eating less while the regimen stays the same can produce a drop in the afternoon.
Delayed gastric emptying from tirzepatide also shifts when glucose from meals enters the bloodstream. A lunch that would previously have raised blood sugar within an hour may now have a delayed and blunted effect.
Tracking your glucose at 3 PM for a week, along with what you ate and when, gives your prescriber the data needed to adjust the regimen appropriately.
My doctor added Mounjaro to metformin. Can this cause low blood sugar?
Metformin alone does not cause hypoglycemia. Mounjaro alone has low intrinsic hypo risk. Together, neither of these should be causing blood sugars in the 50s through direct drug action.
The mechanism is indirect: Mounjaro reduces appetite significantly. If you are eating meaningfully less than you were before starting it, and metformin's dose has not changed, the mismatch between what you are eating and what your body expects from prior calibration can produce lower blood sugars than you were seeing before.
If you add Jardiance (empagliflozin) to this picture, you have three agents all working in the same direction without a corresponding adjustment in intake. The fix is tracking your readings, noting your intake, and having a conversation with your prescriber about whether a timing or dose adjustment makes sense.
When should I go to the ER for low blood sugar?
Go immediately if: blood sugar is below 54 and you cannot raise it with fast carbs, you lose consciousness or have a seizure, you are too confused to treat yourself, or anyone around you cannot be trusted to manage the situation safely.
A blood sugar in the 50s that responds to fast carbs and comes up within 15 minutes is an urgent situation you can manage at home, but it requires follow-up. If you are having recurrent lows, that is a prescriber conversation, not something to manage with snacks and willpower.
Document the low: time of day, what you had eaten and when, what you took to treat it, and what your blood sugar read 15 minutes after treatment. That log is what allows your prescriber to make an informed adjustment.
The MAP Tool maps your medication list, your symptoms, and your patterns to root cause. Not a prescription. A real picture of what is happening.
Start Your Map